A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.

The NK cells are first activated with cytokines ... and vice president and head of MD Anderson's Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her team ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

The NK cells first are activated with cytokines ... and vice president and head of MD Anderson’s Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her team continue ...

The NK cells first are activated with cytokines ... and vice president and head of MD Anderson's Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her team continue ...

The NK cells first are activated with cytokines ... and vice president and head of MD Anderson's Institute for Cell Therapy Discovery & Innovation. Through the institute, Rezvani and her team continue ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the most powerful is cellular senescence. This process stops a cell from ...

Senti Biosciences, Inc.’s SNTI share price has surged by 6.40%, which has investors questioning if this is right time to sell ...

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells.